The U.S. Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.

Dr. Lowe founded Medicanja Ltd — described as “Jamaica's first medical cannabis company” — in 2013.

Its distinguished board of directors includes two former prime ministers and a former governor general.

Click here to read the complete article

GlobalVoices.org via 420Intel.com ~